Navigation Links


Tag: "enron" at medical news

Founder of Enron, Ken Lay Passes Away

Colorado: Ken Lay, the founder of Enron, who was admitted at the Aspen Valley Hospital with a massive coronary, passed away, in the early morning due to a heart attack//. ....The founder and the supposed mastermind behind the Enron scandal had succumbed to his illness just months before his impending sentence on his involvement in the scandal. In May the founder of the Enron Corp. was convicted...
Other Tagswarming 2warming 3warming 4warming 5suffer 2suffer 3suffer 4suffer 5suffer 6suffer 7suffer 8suffer 9suffer 10
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
(Date:10/10/2008)...Yale scientists have created nanowire sensors coup...e both sensitive and specific enough to be used fo... to a report in Nano Letters . , The sensors us...tigens signatures of bacteria, viruses or cancer ..., they produce acid, and generate a tiny current i...
(Date:10/9/2008)...if., Oct. 9 /PRNewswire-FirstCall/ -- Synaptics(R)...r of human interface,solutions for mobile computin...unced today that it will report financial results ...October 23, 2008 after the close of market. The,co...r analysts and,investors at 2:00 p.m. PT (5:00 p.m...
(Date:10/9/2008)...g a mussel: you have to worry about hungry starfis...ronment that can change your body temperature 50 d...ne of the most variable habitats on Earth," said U...t of the day bathed in cool Pacific seawater and t... Gracey led the first real-time molecular sampling...
(Date:10/9/2008)...tute of Allergy and Infectious Diseases (NIAID), p...ll award five-year contracts estimated to be up to...ology for Infectious Disease Research at four rese...l apply novel techniques to study diseases that in...berculosis and influenza. , Systems biology is t...
Breaking Biology News(10 mins):Sensitive nanowire disease detectors made by Yale scientists 2Synaptics to Report First Quarter Results on October 23 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3New Systems Biology Awards enable detailed study of microbes 2TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache 68 1TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache 68 2TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache 68 3TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache 68 4Vical Reports Second Quarter 2007 Financial Results Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 66 1Vical Reports Second Quarter 2007 Financial Results Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 66 2Vical Reports Second Quarter 2007 Financial Results Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 66 3Vical Reports Second Quarter 2007 Financial Results Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 66 4Vical Reports Second Quarter 2007 Financial Results Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 66 5Vical Reports Second Quarter 2007 Financial Results Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 66 6ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen Inc 64 1ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen Inc 64 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen Inc 64 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen Inc 64 4Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 1Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 2Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 3Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 4Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 5Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 6Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 7Amicus Therapeutics Announces Second Quarter 2007 Financial Results 62 8
Other Contentsexpressionexpressionexpressionexpressionexpressionexpressionexpressionexpressionexpressionexpressionflowflowflowflowflowflowflowflowflowflowinteractioninteractioninteractioninteractioninteractioninteractioninteractioninteractionknockoutknockoutknockoutproductproductproductproductproductproductproductproductproductsilencingsilencingsilencingsilencingsilencingsilencingtargetingtargetingtargetingtargetingtargetingtargetingtargeting